Fact-checked by Grok 2 weeks ago

CooperVision

CooperVision, Inc. is a global leader in the design, manufacture, and distribution of soft contact lenses, serving eye care professionals and patients in over 130 countries through innovative vision correction solutions. As a division of The Cooper Companies, Inc. (NYSE: COO), it focuses on advancing contact lens technology to address diverse needs, including daily disposables, toric, multifocal, and specialty lenses for conditions like myopia progression in children. Headquartered in San Ramon, California, CooperVision produces billions of lenses annually and is renowned for its commitment to scientific research, operational excellence, and partnerships with eye care providers worldwide. The company's origins trace back to , founded in 1958 as Martin H. Smith Co., a pharmaceutical business that evolved through expansions and renamings, including to Cooper Laboratories, Inc. in 1967. CooperVision was formally incorporated in 1980 as a dedicated vision care unit, going public in 1983 amid rapid growth in the market, and has since expanded via acquisitions and product innovations, such as the 1979 introduction of Permalens, the first lens approved for 30-day continuous wear. Key milestones include the development of MiSight® 1 day lenses in , clinically proven to slow progression in children aged 8-12 over three years, reflecting CooperVision's emphasis on addressing global vision health challenges like increasing nearsightedness. Today, CooperVision offers one of the broadest portfolios of soft prescriptions, including materials for comfort and DigitalBoost™ tailored to modern digital lifestyles, while maintaining a strong focus on and in its operations across multiple continents. With manufacturing facilities in locations such as , , and the , the company supports a dedicated to and innovation, positioning it as a pivotal player in the evolving eye care industry.

Company Overview

Description

CooperVision is a leading manufacturer of soft contact lenses, specializing in and materials designed for vision correction. Headquartered in , the company emphasizes a broad portfolio of soft prescriptions, including , toric, and multifocal options to address diverse vision needs. As a of , Inc., which was founded in 1958, CooperVision ranks among the top three global manufacturers and produces billions of lenses annually to serve eye care professionals and patients worldwide. The company's mission centers on helping people around the world see better every day by delivering innovative, high-quality contact lenses through ongoing research, operational excellence, and strong partnerships with eye care professionals.

Global Presence

CooperVision maintains a robust international footprint, with its contact lenses sold in over 130 countries worldwide. This extensive distribution network spans major markets including , which accounts for approximately 40% of its sales as of 2024, , the Middle East, and (EMEA) at 38%, and at 22%. The company's global reach ensures accessibility for eye care professionals and consumers, supporting vision correction needs across diverse regions. To facilitate this scale, CooperVision operates major manufacturing and distribution facilities in the United States, , , , , and . These sites produce billions of contact lenses annually, enabling efficient operations that meet demand while adhering to high standards of quality and . As the third-largest provider of contact lenses globally as of 2025, CooperVision holds a significant market position, emphasizing innovation and reliability to drive its competitive edge in the industry. The company fosters strong partnerships with eye care practitioners and retailers to ensure localized distribution and tailored support. Through authorized distributors and collaborative programs, CooperVision equips professionals with resources for fitting and , enhancing product availability and adoption worldwide. This network underscores its commitment to accessible vision care on a global scale.

History

Founding and Early Years

The parent company originated in 1958 as Martin H. Smith Co., a pharmaceutical , which was reorganized and renamed Cooper Laboratories, Inc. in 1967 by Parker Montgomery, a Harvard-educated , initially focusing on pharmaceuticals and health-care products. The company's entry into the contact lens market began in the mid-1960s through involvement with pioneering efforts in soft . In 1965, optometrist Dr. Stanley renamed his Guild—established in 1958—to Gordon Contact Lenses, Inc., where he advanced research into soft contact lenses. In 1970, Union Corporation acquired Gordon's firm, forming UCO Optics, which continued development of hydrophilic materials for vision correction. A significant milestone for the contact lens industry came in 1976 when UCO Optics launched Aquaflex, the third approved by the FDA, utilizing the proprietary tetrafilcon for improved comfort and oxygen permeability. In 1979, CooperVision introduced Permalens, the first FDA-approved for 30-day continuous wear, marking a breakthrough in extended-use technology. In 1980, Cooper Laboratories incorporated CooperVision as a dedicated division to consolidate and expand its contact lens operations. In 1983, CooperVision acquired UCO Optics, integrating its technologies including Aquaflex. That same year, CooperVision went public through an , raising capital amid aggressive expansion.

Growth and Acquisitions

In the mid-1980s, CooperVision faced significant financial pressures amid aggressive expansion. In 1982, interest expenses totaled $25 million, consuming 65% of operating profit due to from prior acquisitions. To stabilize finances, the company launched "Project Supernova" in 1983, which involved divesting portions of subsidiaries, including selling an 18% stake in CooperVision for $60 million to reduce . These efforts enabled , with CooperVision's surpassing $625 million by 1988. In , the parent company, formerly Cooper Laboratories, was renamed , Inc., positioning CooperVision as a unit alongside CooperSurgical in a restructured organization focused on medical devices. The 1990s marked a period of strategic acquisitions and international expansion under new leadership. In , CooperVision acquired CoastVision, Inc., gaining expertise in toric contact lenses for astigmatism correction and broadening its product portfolio. In 1994, Thomas Bender was appointed CEO, guiding the company toward focused growth through targeted mergers and operational efficiencies. This momentum continued with regulatory clearance in March 1999 to enter the Japanese market, the world's second-largest for contact lenses, enhancing global reach. Into the 2000s and 2010s, CooperVision pursued major acquisitions to strengthen its technological capabilities and market position. The 2004 acquisition of Ocular Sciences, Inc., for approximately $1.2 billion, integrated the Biomedics line of soft contact lenses and elevated CooperVision to the third-largest contact lens manufacturer worldwide. In 2014, the company acquired Sauflon Pharmaceuticals Limited for about $1.2 billion, adding advanced silicone hydrogel technology and expanding daily disposable lens offerings. This strategy of portfolio expansion through high-impact deals continued into the 2020s, with acquisitions including GP Specialists in 2020 to enhance myopia management options, No7 Contact Lenses and SightGlass Vision in 2021 for specialty and orthokeratology lenses, and EnsEyes and SynergEyes in 2022 to bolster orthokeratology, scleral, and hybrid lens capabilities in Europe and the U.S. These moves drove sustained revenue growth and innovation in the sector.

Products

Daily Disposable Lenses

CooperVision's daily disposable contact lenses are designed for single-use convenience, eliminating the need for cleaning or storage solutions and making them suitable for users with active or on-the-go lifestyles. These lenses, discarded after one day of wear, help maintain eye health by reducing exposure to potential contaminants accumulated from handling or environmental factors. The MyDay family represents a cornerstone of CooperVision's daily disposable portfolio, featuring patented Smart Silicone™ chemistry that achieves high oxygen permeability with only 4.4% content, the lowest in any daily disposable lens. This technology, combined with Aquaform® Technology, ensures exceptional moisture retention and wettability throughout the day, promoting all-day comfort. Available in spherical, toric for correction, and multifocal variants for , the MyDay lenses cater to a broad spectrum of needs while prioritizing breathability for the . Complementing the MyDay line, Clariti 1 Day lenses utilize somofilcon A material, a with 56% water content, to deliver high oxygen transmission and sustained hydration via WetLoc™ technology. Their aspheric are engineered to minimize spherical aberrations, providing crisp and clear across various lighting conditions. Offered in spherical, toric, and multifocal designs, these lenses are particularly noted for their ease of handling and affordability, supporting corrections for and . A key advantage of CooperVision's daily disposables is their no-cleaning regimen, which appeals to users seeking and hygiene, especially those with busy schedules or concerns. Among major manufacturers, CooperVision offers the widest prescription range in daily disposables, spanning up to +8.00D to -12.00D in spherical powers and extensive options for and add powers in multifocals. Usage data indicates that daily disposables like these are popular for lowering infection risks, as wearers of reusable lenses face nearly four times the likelihood of developing rare but serious conditions such as compared to daily disposable users.

Extended Wear Lenses

CooperVision's extended wear lenses are designed for reusable use, typically on bi-weekly or monthly replacement schedules, providing options for wearers seeking durability and sustained comfort over multiple days. These lenses incorporate to support continuous wear, often up to six nights and seven days, while requiring regular cleaning and storage to maintain eye health. The Biofinity family exemplifies monthly replacement extended wear lenses, utilizing Aquaform technology to achieve natural wettability by forming hydrogen bonds that retain moisture throughout the without surface coatings. This results in high oxygen transmissibility, delivering 100% of the eye's required oxygen to promote during extended use. Available in spherical, toric, and multifocal designs, Biofinity lenses offer broad prescription coverage, including correction for up to 99.9% of astigmatic patients and through Balanced Progressive technology for seamless vision at all distances, emphasizing all-day comfort. The Proclear family provides bi-weekly or monthly replacement options tailored for wearers prone to dryness, featuring PC Technology that integrates phosphorylcholine molecules to bind water and resist , retaining up to 97% of original even after 12 hours. This creates a protective shield against tear , making Proclear particularly suitable for dry eye sufferers seeking extended wear comfort. Like Biofinity, Proclear covers a wide range of prescriptions for and in toric and multifocal variants, prioritizing prolonged for daily activities. For both families, replacement schedules mandate removal after the approved extended wear period, followed by using a multi-purpose : rub the lenses gently between clean fingers, rinse thoroughly, and store in a lens case filled with fresh overnight to prevent protein buildup and . This routine ensures the lenses' durability while supporting cost savings over single-use alternatives through reuse.

Specialty Lenses

CooperVision's specialty lenses address complex vision correction needs, including therapeutic applications for conditions like progression, combined with , , and post-surgical irregularities. These lenses incorporate advanced designs to provide stability, comfort, and targeted optical correction beyond standard spherical or toric options. A flagship product in this category is MiSight 1 Day, the first and only soft FDA-approved to slow the progression of in children aged 8 to 12 at the initiation of treatment. This daily disposable lens employs ActivControl , which features a dual-focus optical design to reduce hyperopic defocus and thereby limit axial elongation of the eye. By intervening early in pediatric eye health, MiSight 1 Day supports long-term ocular wellness, particularly in addressing the global rise in childhood . For patients with both and , CooperVision offers Biofinity Toric Multifocal lenses, which integrate toric stabilization with multifocal to deliver consistent vision across distances. The lens utilizes Optimized Toric Lens Geometry for enhanced rotational stability and Balanced Progressive technology to optimize near, intermediate, and distance vision, ensuring reliable performance for emerging presbyopes with . CooperVision's specialty portfolio also includes options for irregular corneas and challenging prescriptions through its Specialty Eye Care division. For , hybrid lenses like UltraHealth and SynergEyes VS provide a rigid gas-permeable center for sharp vision with a soft skirt for comfort, accommodating the cone-shaped . Post-surgical patients, such as those with corneal after refractive procedures, benefit from scleral lenses like Onefit MED+, which vault over the to promote healing and stability on compromised surfaces. Custom solutions for high prescriptions are available via the Onefit family and SynergEyes iD, offering extensive parameter customization to fit unique corneal topographies and refractive errors. Clinical evidence underscores the efficacy of these specialty lenses, particularly in management. A three-year demonstrated that MiSight 1 Day slowed progression by an average of 59% compared to single-vision lenses, with 41% of treated eyes showing no progression, highlighting its role in preserving pediatric visual health.

Innovation and

Research and Development

CooperVision operates dedicated research and development centers focused on advancing technology through expertise in material science, , and . The company's primary R&D hub is located in , where a team of over 30 PhDs conducts core innovation work, complemented by the Vision Centre in , , a state-of-the-art facility designed to foster technical and collaborative advancements in lens design. These centers emphasize the development of materials that enhance oxygen transmissibility and ocular comfort while optimizing optical performance for diverse vision needs. To support its scientific progress, CooperVision invests significantly in R&D, allocating approximately 3% of its revenue—equating to $73.4 million in —to these efforts, which have resulted in a robust portfolio of patents related to lens designs and . This investment underscores the company's commitment to , yielding over 150 patents assigned to CooperVision in areas such as multifocal optics and silicone hydrogel formulations. Collaborations with eye care professionals and academic institutions further bolster these initiatives; for instance, CooperVision maintains partnerships with 25 universities, including the College of and New England College of , to advance specialty lens research, and has renewed a multi-year agreement with Indiana University School of for joint development activities. The R&D processes at CooperVision employ a multidisciplinary approach, integrating optometrists, chemists, engineers, and clinical researchers to ensure comprehensive of lens prototypes. Iterative testing protocols assess key performance metrics, including wearer comfort, (measured via Dk values in silicone hydrogel materials), and quality through simulated wear scenarios and user feedback loops. These efforts culminate in rigorous clinical trials to secure FDA approvals, as demonstrated in multi-year studies evaluating lens safety and efficacy against benchmarks like reduced corneal . This framework has notably supported outcomes such as the MiSight 1 day lenses, approved for management following a three-year randomized trial.

Key Advancements

CooperVision has made significant contributions to technology since its early years, beginning with pioneering soft lens materials. In 1976, the company introduced Aquaflex, crafted from tetrafilcon A, which became the third soft available on the market and helped establish daily wear options for vision correction. In the early 1980s, CooperVision launched Permalens, one of the first extended-wear soft lenses designed for continuous use, addressing the need for longer-lasting correction without daily removal. Following the 2004 acquisition of Ocular Sciences, CooperVision integrated the Biomedics product line, which expanded its portfolio with advanced hydrogel lenses offering improved comfort and oxygen transmissibility. A major advancement came with the development of hydrogel materials, which enhance oxygen permeability to the , minimizing hypoxia-related issues such as dry eye and discomfort during wear. These materials represent a shift from traditional hydrogels by incorporating for better while maintaining high for . For instance, Smart Silicone chemistry in MyDay daily disposable lenses uses a proprietary structure with fewer silicone-water interactions, resulting in lenses that feel softer and more naturally wettable than earlier generations. Similarly, Aquaform in Biofinity lenses hydrates the material to twice its dry weight in water, promoting uniform moisture retention and reducing end-of-day dryness. In myopia management, ActivControl Technology marks a breakthrough for pediatric care, utilizing a dual-focus optic profile in MiSight 1 day lenses to simultaneously correct vision and slow axial eye elongation in children aged 8-12. This design creates peripheral defocus to counteract the signals driving progression, with clinical evidence showing reduced progression rates compared to standard single-vision lenses. In August 2025, MiSight 1 day became the first soft approved for myopia control in . To address digital eye strain, DigitalBoost Technology introduces an aspheric lens design that delivers a +0.3D power boost, easing ciliary muscle fatigue from frequent focus shifts between digital screens and distant objects. Integrated into lenses like Biofinity Energys and MyDay Energys, this innovation supports all-day comfort for users engaged in prolonged digital activities without altering central vision correction. In 2024, CooperVision unveiled clariti 1 day multifocal contact lenses, providing a new option for presbyopia management with high-definition optics for clear vision at near, intermediate, and far distances.

Operations and Sustainability

Manufacturing and Supply Chain

CooperVision maintains a network of key manufacturing facilities across multiple countries to support its global operations. Primary sites include the plant in Scottsville, New York, for lens production and packaging; Juana Díaz and Ponce, Puerto Rico, focused on high-volume molding, assembly, and innovative lens production; Alajuela, Costa Rica, dedicated to contact lens manufacturing; and Hamble, United Kingdom, handling molding, coating, and finishing processes. These facilities employ automated injection molding techniques to produce billions of soft contact lenses annually, incorporating robotic systems for precision shaping of lens blanks from materials and integrated measures such as optical inspection and defect detection to maintain uniformity. The company's emphasizes efficient sourcing of raw materials, including monomers essential for and hydrogel formulations, managed by a dedicated Team that tracks supplier risks and ensures a reliable flow to meet demand across more than 130 countries. Production adheres to rigorous quality standards, with facilities certified under for medical device quality management and fully compliant with FDA requirements for sterility, , and dimensional precision in Class II and III devices.

Sustainability Initiatives

CooperVision has implemented several programs aimed at minimizing from its and processes. Through a partnership with Plastic Bank initiated in 2021, the company funds the collection and of ocean-bound equivalent to the used in its products, achieving net neutrality for its daily disposable lenses sold in 34 countries and territories as of August 2025. This initiative has prevented more than 10.26 million kilograms of —equivalent to 513 million bottles—from entering oceans by April 2025, while supporting livelihoods in 519 coastal through incentives like access to vision care services. Additionally, CooperVision promotes consumer of blister packs via programs in select markets, such as , to further reduce landfill contributions. In terms of sustainable materials, CooperVision incorporates eco-friendly polymers in its , notably sourcing ISCC PLUS-certified plastics that lower the of by approximately 50% compared to traditional fossil-based inputs (from 1.63 kg CO2e/kg to -0.82 kg CO2e/kg for ). The company also focuses on reducing and in through optimizations, such as 20% lower usage across key lines, saving over 820,000 kWh annually. These efforts extend to facility certifications, with six global sites—including those in , , the , and —achieving Facility Program certification in 2025, diverting over 90% of waste through , composting, and . On the social front, CooperVision supports eye health access in underserved regions as a lead sponsor of Giving Sight, contributing more than $5 million to serve more than 7.6 million people, train over 14,000 eye care professionals, and establish 130 vision centers across six continents. The company promotes workforce diversity, with women comprising 49% of its global employees and 50% of director-level roles, alongside over 2,600 participants in Employee Resource Groups and a perfect score on the Human Rights Campaign's for LGBTQ+ inclusion. CooperVision's corporate goals align with the , particularly SDG 3 (Good Health and Well-Being) through vision initiatives and SDG 12 (Responsible Consumption and Production) via waste reduction efforts, as outlined in its parent company's reporting. The firm reports annually on reductions, achieving 100% renewable electricity sourcing at its and facilities, with Scope 1 and 2 at 73,846 metric tons of CO2e in 2024 (market-based), amid ongoing targets to eliminate waste and expand certifications.

References

  1. [1]
    About CooperVision Bringing better vision to the world
    CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellenceContact Us · Corporate social responsibility · Our work and values · Our Leadership
  2. [2]
    Cookie Notice | CooperVision
    You can contact us, CooperVision Inc., with its head office at 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA 94583; by e-mail: dpo@coopervision.com or by ...
  3. [3]
    John Weber - Our Storied History - CooperVision
    Mar 11, 2013 · To get the full picture of CooperVision's origins, we need to refer back to our parent company, The Cooper Companies, Inc., and its long history ...
  4. [4]
    History of The Cooper Companies, Inc. – FundingUniverse
    1979: CooperVision introduces Permalens, the first contact lens approved for 30-day continuous wear. 1983: UCO Optics is acquired.
  5. [5]
    CooperVision's Global Presence
    Jul 15, 2013 · From our corporate headquarters in Pleasanton, CA, to our manufacturing plants in Juana Díaz, Puerto Rico; Scottsville, New York; and Hamble ...
  6. [6]
    Who We Are - CooperCompanies
    He was previously the President of CooperVision, our contact lens subsidiary, from February 2014 through January 2022.
  7. [7]
    Next Generation Contact Lenses Market - Global Industry Analysis
    Cooper Vision is a second-leading player with a 27.0% market share, and its products are known for their high-quality and comfort-oriented designs, such as ...
  8. [8]
    Our work and values - CooperVision
    CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing ...
  9. [9]
    CooperVision forecasts further market share gains in FY 2025 | Article
    Dec 5, 2024 · CooperCompanies has announced a 9 percent year-on-year increase in Q4 revenue to $676.4 million for CooperVision, in line with the growth ...<|control11|><|separator|>
  10. [10]
    [PDF] Form 10-K for Cooper Companies INC filed 12/06/2024
    Dec 6, 2024 · CooperVision's major manufacturing and distribution facilities are located in Belgium, Costa Rica, Hungary, Puerto Rico, the United Kingdom and ...
  11. [11]
    CooperVision - Greater Rochester Enterprise
    Aug 24, 2022 · CooperVision, the second largest contact lens manufacturer in the world, plans to invest $62 million and create 170 new jobs in the Greater ...
  12. [12]
    CooperVision's U.S. Authorized Distributors
    The following list represents all of CooperVision's' U.S. Authorized Distributors: · ABB/CONCISE · NASSAU LENS CO INC. · NEW ERA · THE NEWTON GROUP, INC. · WISCONSIN ...
  13. [13]
    The Cooper Companies, Inc. -- Company History
    After an extensive development phase, UCO Optics used its proprietary tetrafilcon to unveil its Aquaflex brand in 1976, the third soft contact lens to be ...
  14. [14]
    BUSINESS PEOPLE; Founder's Deal-Making At Cooper Laboratories
    Apr 27, 1984 · Parker G. Montgomery, founder and chairman of Cooper Laboratories, likes to make deals, which in his case means he buys companies, builds ...
  15. [15]
    CooperVision History: Founding, Timeline, and Milestones - Zippia
    In 1987, CooperVision, Inc. changed its name to The Cooper Companies, Inc. and organized into three groups: Cooper Technicon, CooperSurgical, and CooperVision.
  16. [16]
    https://www.zippia.com/coopervision-careers-1186469/history/
  17. [17]
    Contact Lens Pioneers - Review of Optometry
    Aug 15, 2007 · Dr. de Carle sold the rights to the technology, which was eventually acquired by CooperVision. The Permalens was introduced in the United ...
  18. [18]
    History Of Contact Lenses - Contact Lens Spectrum
    Nov 30, 2021 · 1979—CooperVision launched the aphakic Permalens soft lens for 30 days of continuous wear. 1981—Hydrocurve and Permalens were introduced as ...<|control11|><|separator|>
  19. [19]
    The Cooper Companies to Acquire Ocular Sciences
    Jul 28, 2004 · They have signed a definitive agreement for Cooper to acquire Ocular Sciences, Inc. in a merger for stock and cash having a value of $44.00 per share of Ocular ...
  20. [20]
    The Cooper Companies Completes Acquisition of Sauflon ...
    The Cooper Companies Completes Acquisition of Sauflon Pharmaceuticals and Announces $700 Million 3-Year Term Loan. Aug 6, 2014. Download ...
  21. [21]
    Daily Disposable Contact Lenses - CooperVision
    Daily disposable contact lenses may be the best choice for you. The daily schedule, your personal preferences, and your budget can impact your decision.
  22. [22]
    CooperVision Introduces MyDay® Lenses in the U.S.
    Jun 25, 2015 · Smart Silicone optimizes oxygen permeability in a lens that is just 4.4% silicon—the lowest percentage of silicon found in a silicone hydrogel, ...
  23. [23]
    MyDay® | CooperVision Practitioner
    MyDay daily disposable lenses feature Aquaform Technology, which provides a unique balance of high oxygen permeability, high water content and optimum modulus.MyDay® toric · MyDay® family · MyDay® multifocal · MyDay Energys
  24. [24]
    clariti® 1 day | CooperVision Practitioner
    Features · unbeaten handling · all day comfort · easy to insert and remove · silicone hydrogel lens for $1 a day · high oxygen transmission for a healthy lens ...
  25. [25]
    [PDF] clariti 1 day contact lens - CooperVision
    Clariti 1 Day (somofilcon A) Soft (hydrophilic) Daily Disposable Contact Lenses with UV Blocker are made from somofilcon A with a water content of 56% and are ...<|control11|><|separator|>
  26. [26]
    clariti® 1 day multifocal 3 Add | CooperVision Practitioner
    CooperVision 1 day silicone hydrogel multifocals have the widest range versus competitor 1-day multifocals enabling you to fit more patients with presbyopia2.
  27. [27]
    Reusable contact lenses more than triple risk of rare preventable ...
    Sep 23, 2022 · People who wear reusable contact lenses are nearly four times as likely as those wearing daily disposables to develop a rare sight-threatening eye infection.
  28. [28]
    Extended Wear Contact Lenses | CooperVision
    Extended wear contacts are, most typically, contact lenses that can be worn continuously for up to six nights and seven days.Missing: first FDA
  29. [29]
    Biofinity® Contact Lenses | Practitioner - CooperVision
    Clear vision with up to 6 nights/7 days of extended wear. Family products. Biofinity Energys® Monthly Nearsighted/Farsighted.Biofinity® & Biofinity® XR · Biofinity® toric & Biofinity® XR... · Biofinity Energys
  30. [30]
    Aquaform® Technology - CooperVision
    Aquaform Technology is an innovative contact lens material technology that results in natural wettability and incredible comfort.
  31. [31]
    Biofinity® contact lenses - CooperVision
    Biofinity contacts from CooperVision are premium lenses, offering luxurious extended-wear comfort. Click through to discover the full range.
  32. [32]
    Biofinity® toric & Biofinity® XR toric | CooperVision Practitioner
    Highly customized, extended range Biofinity® XR toric contact lenses are made to order and ship to patients within 10 days.*4; For every Biofinity® lens you fit ...
  33. [33]
    Biofinity® multifocal | CooperVision Practitioner
    Clear, comfortable vision for patients with presbyopia. · Balance Progressive® Technology provides remarkable vision at all distances—optimized for each sphere ...
  34. [34]
    PC Technology™ | CooperVision Practitioner
    PC Technology lenses retain up to 97% of their original water content, even after 12 hours of wear—offering true all-day comfort for your patients ...
  35. [35]
    Proclear® sphere | CooperVision Practitioner
    Proclear sphere lenses stay 96% hydrated, may help with dryness, and use PC Technology to bind water, creating a shield for all-day comfort.Missing: extended | Show results with:extended
  36. [36]
    Proclear® multifocal toric - CooperVision
    Proclear multifocal toric helps provide all-day comfort for multifocal contact lens wearers with astigmatism who experience dry eyes related to lens wear.Missing: extended | Show results with:extended
  37. [37]
    Cleaning Contact Lenses | CooperVision
    1. Wash your hands with soap and water before touching your contact lenses. Use antibacterial soap where possible, and dry your hands with a lint-free towel.Missing: extended | Show results with:extended
  38. [38]
    Contact Lens Care Instuctions | CooperVision
    Use fresh solution, rub and rinse lenses, avoid tap water, don't share, and don't sleep in non-extended wear contacts. Handle gently and keep fingernails away.Stick To Your Prescribed... · Contact Lenses: Handle With... · Don't Sleep In Contacts That...
  39. [39]
    CooperVision Specialty – Bringing together of the knowledge ...
    CooperVision Specialty represents the bringing together of the knowledge, experience, and bold lineage of leading specialty vision companies.Missing: retailers | Show results with:retailers
  40. [40]
    MiSight® 1 day - CooperVision
    MiSight® 1 day from CooperVision are child-friendly daily disposable contact lenses proven to slow the progression of nearsightedness in children aged 8-12 ...Sustainability · Misight 1 Day · The Features You'll Love
  41. [41]
    MiSight® 1 day | CooperVision Practitioner
    Features · Easy to fit, single use lens · The FIRST and ONLY soft contact lens designed for myopia control and is FDA-approved* to slow the progression of myopia ...Features · Lens Technology · Activcontrol® Technology
  42. [42]
    MiSight® 1 day for myopia control | CooperVision
    Meet MiSight® 1 day soft contact lenses specifically designed for myopia control and FDA approved to slow the progression of myopia in children ages 8-12.MiSight® 1 day Blog · MiSight® 1 day in the news · Free trial & rebate offer · FAQs
  43. [43]
    Biofinity® toric multifocal | CooperVision Practitioner
    A multifaceted toric lens that's designed to provide predictable, consistent visual acuity, lens stability, fit and comfort.
  44. [44]
    Biofinity® toric multifocal - CooperVision
    Biofinity® toric multifocal contact lenses from CooperVision deliver performance to contact lens wearers who are both astigmatic and presbyopic.
  45. [45]
    A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia ...
    The purpose of this study was to quantify the effectiveness of MiSight daily disposable soft contact lens in slowing the progression of juvenile-onset myopia.
  46. [46]
    Our Technical Expertise | CooperVision
    CooperVision has a long history of bringing innovation to our contact lenses and overcoming technical problems like difficult fittings.
  47. [47]
    CooperVision Unveils Plans for The Vision Centre: the Workplace of ...
    Jul 4, 2024 · CooperVision has announced plans for a new, state-of-the art technical, commercial and business hub in Southampton, UK, reinforcing its commitment to ...
  48. [48]
    [PDF] 1K1313-1 S - accessdata.fda.gov
    Jul 16, 2013 · " The lenses are made of a silicone hydrogel material which is not surface treated and is characterized by high oxygen permeability (Dk).Missing: processes iterative
  49. [49]
    https://www.misight.com/
  50. [50]
    Patents Assigned to CooperVision - Justia Patents Search
    Patent number: 12259597. Abstract: A multifocal ophthalmic lens wherein a first surface of the lens is shaped to form a surface power map and a second ...
  51. [51]
    CooperVision Specialty EyeCare Partners Now Partners With 25 ...
    Jun 1, 2022 · The company has grown the partnership to 25 universities, including New England College of Optometry, the University of Houston College of ...
  52. [52]
    IU School of Optometry and CooperVision renew research partnership
    Nov 13, 2017 · School leaders and representatives from CooperVision signed a five-year agreement to support research and related development activities.Missing: patents eye professionals
  53. [53]
    NCT05285527 | MiSight 1 Day Safety Post-Approval Study
    This prospective post-approval study of safety in a US study population is to confirm the safety of MiSight 1 day lenses. Consecutive subjects receiving the ...Missing: iterative oxygen permeability
  54. [54]
    CooperVision - Contact Lenses
    In 2004 CooperVision acquired Ocular Sciences Inc., a company that ... , a company that manufactures three different contact lenses: Biomedics 38, Biomedics 55 ...
  55. [55]
    SILICONE HYDROGEL Contact Lenses | CooperVision Practitioner
    With higher oxygen permeability than hydrogel materials, silicone hydrogel contact lenses minimize or eliminate hypoxia-related signs and symptoms during lens ...Missing: advancements Aquaflex Permalens Biomedics
  56. [56]
    Smart Silicone™ chemistry | CooperVision Contact Lenses
    Smart Silicone chemistry is a unique chemical structure that's exclusive to CooperVision MyDay daily disposable contact lenses.
  57. [57]
    Aquaform® Technology | CooperVision Practitioner
    Contact lenses with Aquaform technology are hydrated to twice their weight in water making them highly moist and naturally wettable.
  58. [58]
    ActivControl® Technology - CooperVision
    Special contact lens technology for children that corrects their vision while slowing myopia progression in children (aged 8-12 at the initiation of treatment) ...Missing: key advancements silicone hydrogel Aquaflex Biomedics
  59. [59]
    DigitalBoost™ Technology | CooperVision Practitioner
    An innovative single vision aspheric lens design that delivers a +0.3D boost, which helps reduce eye tiredness associated with digital device use.Missing: key advancements silicone hydrogel Aquaflex Permalens Biomedics
  60. [60]
    DigitalBoost™ Technology: Lens Design Fit for Today - CooperVision
    An innovative single vision aspheric lens design that delivers a +0.3D digital boost, which helps reduce eye tiredness associated with digital eye strain.Benefits · Biofinity Energys · Myday Energys
  61. [61]
    CooperVision to Invest $500 Million in Puerto Rico Operations ...
    Jun 6, 2023 · CooperVision will enlarge production in Juana Diaz, add a new manufacturing site in Ponce, and expand warehousing and packaging lines in Juana ...
  62. [62]
    CooperVision Costa Rica Manufacturing Facility Earns Prestigious ...
    Aug 11, 2022 · CooperVision's contact lens manufacturing facility in Alajuela, Costa Rica has been elevated to the prestigious LEED® Gold status following program ...
  63. [63]
    CooperVision Achieves Prestigious LEED® Gold Certification At ...
    CooperVision has achieved another milestone in its sustainability journey with two of its facilities in Hampshire, UK, being awarded the prestigious LEED® Gold ...
  64. [64]
    An eye for improvement - Planet Lean
    Jun 21, 2022 · ... CooperVision has its own “special recipe”. In truth, however, the key step in the manufacture of soft contact lenses is injection molding.
  65. [65]
    CooperVision Global Packaging and Distribution Center Earns ...
    Jul 6, 2023 · In 2021, CooperVision pioneered the world's first plastic ... contact lens industry, out of the top 4 global contact lens manufacturers.Missing: ranking | Show results with:ranking
  66. [66]
    [PDF] Supply Chain Management
    The sourcing of critical materials within CooperVision is managed by the Global Sourcing Team, which maintains a risk tracker for each supplier. The risk ...
  67. [67]
    [PDF] CooperVision Supplier Code of Conduct
    Suppliers must establish controls to demonstrate chain of custody, identifying all upstream. Suppliers from raw materials to finished products or services being ...
  68. [68]
    [PDF] K220070.pdf - accessdata.fda.gov
    Feb 4, 2022 · The lenses may be worn by persons who exhibit astigmatism of -2.00 diopters or less that does not interfere with visual acuity. MyDay ( ...Missing: iterative | Show results with:iterative<|separator|>
  69. [69]
    [PDF] CooperVision, Inc. Ms. Marie Dutton Senior Regulatory Affairs ...
    Mar 23, 2020 · Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA ...
  70. [70]
    CooperVision Expands Plastic Neutral Contact Lens Initiative into ...
    Aug 4, 2025 · Through this collaboration, CooperVision funds the collection and recycling of ocean-bound plastic equivalent to the weight of plastic used in ...
  71. [71]
    [PDF] 2023 ESG Report - Cooper Companies
    Our commitment to sustainability continues to evolve alongside our business. We maintain 100% renewable electricity sourcing at all CooperVision facilities in ...
  72. [72]
    Sustainability News & Accolades - CooperVision
    Further extending its global sustainability efforts, CooperVision has launched an initiative in Sweden that offers consumers free soft contact lens recycling ...
  73. [73]
    Our Work | CooperVision
    Discover CooperVision's efforts to reduce plastic waste, source responsibly, and inspire employee innovation for a more sustainable future.
  74. [74]
    CooperVision Achieves Zero Waste Certification at Six Global ...
    Mar 10, 2025 · CooperVision has earned Zero Waste Facility Program Certification for six of its global contact lens manufacturing and distribution sites.Missing: ranking | Show results with:ranking
  75. [75]
    Corporate social responsibility - CooperVision
    Provided basic eye care services to over 7.6 million people; Trained more than 14,000 eye care personnel; Supported the establishment of over 130 vision centers.Missing: diversity | Show results with:diversity
  76. [76]
    Sustainability Reporting - CooperCompanies
    We've aligned our sustainability efforts with the United Nations Sustainable Development Goals, aimed at protecting the planet and ensuring prosperity and peace ...
  77. [77]
    The Cooper Companies Supports United Nations Sustainable ...
    Jun 5, 2019 · The Cooper Companies, Inc. (NYSE:COO) today announced its alignment with the United Nations Sustainable Development Goals (SDGs).<|separator|>